申请人:Schering Aktiengesellschaft
公开号:US06391887B1
公开(公告)日:2002-05-21
The invention relates to compounds of formula (I), as defined herein. The invention also relates to the use of the inventive compounds for treatment of a disease caused by the effects of nitrogen monoxide in pathological conditions.
该发明涉及公式(I)所定义的化合物。该发明还涉及将这些创新化合物用于治疗由氮氧化物在病理条件下引起的疾病。